India’s first CRISPR Covid-19 test, developed by the Tata Group and CSIR-IGIB, approved for use in India

News: The Tata CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) test, powered by CSIR-IGIB (Institute of Genomics and Integrative Biology) FELUDA, received regulatory approvals from the Drug Controller General of India (DCGI) for commercial launch. Facts: FELUDA is the acronym for FNCAS9 Editor Linked Uniform Detection Assay. It is a low cost paper strip test… Continue reading India’s first CRISPR Covid-19 test, developed by the Tata Group and CSIR-IGIB, approved for use in India

Blog
Academy
Community